

Recent Posts
- GeneVentiv Invited to Present at BioPharm America 2023
- Rare Disease Advisor – An Interview with Damon Race, President and CEO of GeneVentiv Therapeutics
- GeneVentiv Welcomes New Advisors
- GeneVentiv Invited to Present in Labcorp’s Symposium at the 26th Annual Meeting of the American Society of Cell and Gene Therapy
- GeneVentiv Invited to Present at The National Hemophilia Foundation’s 17th Workshop
Recent Comments